<\/p>\n
Speakers<\/span><\/strong>: Prof. Miquel Vila (VHIR) and Prof. Josep Dalmau (IDIBAPS)<\/span><\/p>\n When<\/span><\/strong>: <\/span><\/strong>31st<\/sup> January 2017, 18:00h<\/span><\/p>\n Where:<\/span><\/strong> ICREA, Pg. Llu\u00eds Companys 23, 6th floor<\/span><\/p>\n Abstract<\/span><\/strong>:<\/span><\/p>\n Studies during the last 10 years have revealed a new category of brain diseases in which crucial neuronal receptors are attacked by autoantibodies. As a result of this attack there is a reduction of the target synaptic proteins leading to alterations in synaptic transmission. The clinical manifestations vary according to the receptor involved, and may resemble many of the symptoms caused by neurodegenerative diseases in which specific receptors are involved, including among others Parkinson, epilepsy, chronically progressive sleep disease, or schizophrenia. <\/span><\/span><\/p>\n The ICREA colloquia are a great way to learn about remote fields of research from our best experts. We usually have two speakers, who offer their opinions on the same subject from very different angles. Open to all ICREAs and their guests. There\u2019s wine and munchies at the end, please book in advance!<\/span><\/p>\n","protected":false},"excerpt":{"rendered":" Speakers: Prof. Miquel Vila (VHIR) and Prof. Josep Dalmau (IDIBAPS) When: 31st January 2017, 18:00h Where: ICREA, Pg. Llu\u00eds Companys 23, 6th floor Abstract: Studies during the last 10 years have revealed a new category of brain diseases in which crucial neuronal receptors are attacked by autoantibodies. As a result of this attack there is […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[60],"tags":[],"class_list":["post-18665","post","type-post","status-publish","format-standard","hentry","category-actividades"],"acf":[],"yoast_head":"\n